Pages that link to "Q48609141"
Jump to navigation
Jump to search
The following pages link to Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis (Q48609141):
Displaying 2 items.
- Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis (Q28069975) (← links)
- Analytical Issues with Natriuretic Peptides - has this been Overly Simplified? (Q37229313) (← links)